PRECLINICAL DEVELOPMENT OF MOXIDECTIN AS A NOVEL THERAPEUTIC FOR ALCOHOL USE DISORDER

Current pharmacotherapies for alcohol used disorder (AUD) are few and relatively ineffective illustrating the need for the development of new, effective medications. Using a translational approach, our laboratory reported that ivermectin, an FDA-approved, human and animal anti-parasitic agent, can s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropharmacology
Autors principals: Huynh, Nhat, Arabian, Natalie, Naito, Anna, Louie, Stan, Jakowec, Michael W., Asatryan, Liana, Davies, Daryl L.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5148646/
https://ncbi.nlm.nih.gov/pubmed/27641072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2016.09.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars